1 / 9

Aarkstore - Oncology Research Digest H1 2014

The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cancer and drugs such as Rituxan, Avastin, Herceptin, Traceva, Xeloda, Gleevec, Revlimid, Alimta, Velcade. Browse full report @ http://bit.ly/1EtYhYE

addyparker2350
Download Presentation

Aarkstore - Oncology Research Digest H1 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category : Pharmaceuticals & Healthcare Market Oncology Research Digest H1 2014 www.aarkstore.com

  2. Summary The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cancer and drugs such as Rituxan, Avastin, Herceptin, Traceva, Xeloda, Gleevec, Revlimid, Alimta, Velcade. It is gathered from over 50 sources including associations, consultants, market intelligence companies, investment banks, and industry participants. www.aarkstore.com

  3. Updated quarterly, the Digest allows you to:  • Quickly update yourself on the latest research findings, gathered and organised for you. • Get our Expert Analysts’ perspectives on the latest research. • Link through to the original research to review or purchase. Browse Complete Report - http://www.aarkstore.com/pharmaceuticals-healthcare/94728/oncology-research-digest-h1-2014 www.aarkstore.com

  4. Executive Summary Oncology Research Digest H1 2014 finds that the cancer market is successfully adapting to challenges. Patent expires and payer pressures have led to relatively slow growth in the cancer market in the last five years, and this will continue to be a feature. However the launch of new drugs for the treatment of various types of cancers including lung, blood and pancreatic cancer are expected to drive growth. New drugs will also drive global markets for Non-Small Cell Lung Cancer, Anti- Cancer and Lymphocytic Cancer. These new products will change the shape of the market, with players such as Johnson and Johnson coming to the fore.In terms of geographies, the US market continues to lead with the prices of cancer drugs and treatment costs increasing due to the shift in the US healthcare system. The Asia Pacific region looks the most attractive geography in terms of potential, however the Indian and Chinese markets remain hindered by local market factors.  www.aarkstore.com

  5. Some highlights from the Digest include: • Global Prostate Cancer Therapeutics Market Has Good Commercial Potential• Physicians in China Prescribe Less Expensive Drugs First• Caribbean Countries Present Opportunities for Pharmaceutical Companies• Johnson & Johnson to Emerge as a Key Oncology Player• Shift in the US Health Care Systems Increased the Cost of Cancer Treatment• Branded Drugs Adoption to Drive Breast Cancer Market www.aarkstore.com

  6. Table of Content 1_Global Oncology Research1.1._Global Oncology Spending Growth Declined (2008-2013)1.2._Who Are The Leading Players In the Cancer Drugs Market in 2013 and 2018?1.3._Johnson & Johnson to Emerge as a Key Oncology Player1.4._New Drugs Launch Will Expand Global Market Size for Anti-Cancer Kinase Inhibitor Drugs1.5._Biosimilars Contribution in Biologics Market for Oncology Treatment Remains Low1.6._Immunotherapies Have Potential for Non-Small Cell Lung Cancer Treatment1.7._Global Cancer Immunotherapy Market Expected To Soar To 20221.8._Pancreatic Cancer Treatment Market Forecast to Grow Slowly1.9._New Drugs to Drive Chronic Lymphocytic Leukemia Treatment Market1.10._Bladder Cancer Market Will Grow Slowly1.11._Breast Cancer the Second Most Common Cancer Globally1.12._Branded Drugs Adoption to Drive Breast Cancer Market1.13._Ovarian Cancer Therapeutics Market Growth Minimized By Approved Therapies Shortage www.aarkstore.com

  7. Table of Content 2_The Americas Oncology Research2.1._Prices of Cancer Drugs Increasing In the USA2.2._Shift in the US Health Care Systems Have Increased the Cost of Cancer Treatment2.3._Caribbean Countries Present Opportunities for Pharmaceutical Companies2.4._Prostate Cancer: The Second Leading Cause of Cancer Death in Men in the USA 3_Asia Pacific Oncology Research3.1._Asia Accounts for Nearly Half of the Total Global Cancer Incidence3.2._Asian NSCLC Treatment Market Will Grow Only Marginally In Spite of Expected Drug Launches3.3._Increased Adoption of Branded Drugs Expands Breast Cancer Market in Asia-Pacific Region3.4._China’s Gastric Cancer Drug Market Increased after Herceptin’s Approval to Treat Gastric Cancer3.5._Physicians in China Prescribe Less Expensive Drugs First3.6._Absence of Reimbursement Limits Breast Cancer Treatment in China3.7._Issues for Foreign Pharmaceutical Companies in China www.aarkstore.com

  8. Related Reports • Peritoneal Cancer - Pipeline Review, H1 2015 • Oral Mucositis - Pipeline Review, H1 2015 • Bacterial Vaginosis - Pipeline Review, H1 2015 • Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2015 • Sedation - Pipeline Review, H1 2015 • Cystic Fibrosis Market in Europe 2015-2019 • Global Ultrasound Equipment Market 2015-2019 • Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 www.aarkstore.com

  9. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com

More Related